Effects of combined intralesional 5- fluorouracil and topical silicone in prevention of keloids; a double blind randomized clinical trial study

Acta Medica Iranica

Volumn 49, Issue 3, 2011, Pages 127-130

  Hatamipour, Ebrahim ^a   Mehrabi, Saadat ^a   Hatamipour, Mohsen ^a   Shirazi, Hamid Reza Ghafarian ^a,b  

^a YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Administration; Fluorouracil; Keloid; Silicones; Topical

Indexed keywords

FLUOROURACIL; SILICONE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE PAIN; KELOID; LOCAL EXCISION; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCAR FORMATION; SKIN BURNING SENSATION; SKIN ULCER;

ADMINISTRATION, TOPICAL; ADULT; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; MALE; MIDDLE AGED; SILICONES; YOUNG ADULT;

EID: 79958035518     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Blackburn WR, Cosman B. Histologic basis of keloid and hypertrophic scar differentiation. Clinicopathologic correlation. Arch Pathol 1966;82(1):65-71.
2. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002;204(2):130-132.
3. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25(3):224-232.
4. Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg 1996;37(2):167-169.
5. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002;138(9):1149-1155.
6. Zouboulis CC, Blume U, Büttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol 1993;129(9):1146-1151.
7. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002;204(2):130-132.
8. Uppal RS, Khan U, Kakar S, Talas G, Chapman P, McGrouther AD. The effects of a single dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg 2001;108(5):1218-1224.
9. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, Stefanaki K, Argyrakos T, Petridis A, Katsambas A. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol 2005;52(3 Pt 1):474-479.
10. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004;30(1):54-56; discussion 56-57.
11. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 2004;45(2):140-143.
12. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006;117(1):286-300.
13. Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 2003;4(4):235-243.
14. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006;18(4):396-402.